This cost-of-illness analysis for the United Kingdom is part of a Europe-wide study on the
costs of multiple sclerosis (MS). The objective was to analyze the costs and quality of life …

This cost-of-illness analysis based on information from 1.549 patients in The Netherlands is
part of a Europe-wide study on the costs of multiple sclerosis (MS). The objective was to …

This cost-of-illness analysis for Belgium is part of a Europe-wide study on the costs of
multiple sclerosis (MS). The objective was to analyze the costs and quality of life (QOL) …

The study objective was to analyse the costs and quality of life (QOL) of multiple sclerosis
(MS) related to disease severity in Sweden as part of a study in nine European countries …

This cost-of-illness analysis, based on information from 1101 patients in Switzerland, is part
of a Europe-wide cost-of-illness study in multiple sclerosis (MS). The objective was to …

This cost-of-illness analysis is part of a Europe-wide study on the costs of multiple sclerosis
(MS) and is based on information from patients in Austria. The objective was to estimate the …

The objective of this observational study in nine European countries was to establish the
current cost of MS at different levels of disease severity. The study used a prevalence-based …

We performed a cross-sectional, bottom-up observational study of resource consumption
and quality of life of patients with multiple sclerosis (MS) in the United Kingdom. Three …

This cost-of-illness analysis based on information from 2973 patients with multiple sclerosis
(MS) in Germany is part of a Europe-wide study on the costs of MS. The objective was to …

This cost-of-illness analysis based on information from 921 patients in Italy is part of a
Europe-wide cost-of-illness study in multiple sclerosis (MS). The objective was to analyze …